ID

26045

Description

Study ID: 100601 Clinical Study ID: LPL100601 Study Title: LPL100601, A Clinical Outcomes Study of Darapladib versus Placebo in Subjects with Chronic Coronary Heart Disease to Compare the Incidence of Major Adverse Cardiovascular Events (MACE) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00799903 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: darapladib Trade Name: darapladib Study Indication: Atherosclerosis Study part: Pharmacokinetics - Repeating form (Scheduled visits)

Mots-clés

Versions (4)
  1. 05/10/2017 05/10/2017 -
  2. 16/10/2017 16/10/2017 -
  3. 23/10/2017 23/10/2017 -
  4. 03/01/2018 03/01/2018 -
Détendeur de droits

GlaxoSmithKline

Téléchargé le

5 octobre 2017

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY-NC 3.0
Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Retour au modèle Commentaires
Groupe Item commentaires pour :

Item commentaires pour :

  • Plus récent
  • Plus ancien
  • Favori
  • Plus récent
    • Plus récent
    • Plus ancien
    • Favori

Aucun commentaire

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Pharmacokinetics GSK study Chronic Coronary Heart Disease NCT00799903

Anglais

Pharmacokinetics GSK study Chronic Coronary Heart Disease NCT00799903

1 Formulaires  
An unscheduled PK blood sample must be obtained within 72 hours of last dose
Description

An unscheduled PK blood sample must be obtained within 72 hours of last dose

1. Was a pharmacokinetic blood sample obtained?
Description

pharmacokinetic blood sample

Type de données

boolean

If yes, date taken
Description

Date of blood sample

Type de données

date

If yes, time taken
Description

Time of blood sample

Type de données

time

If Yes, date of last investigational product dose prior to PK sample
Description

date of last investigational product dose prior to PK sample

Type de données

date

If Yes, time of last investigational product dose prior to PK sample
Description

time of last investigational product dose prior to PK sample

Type de données

time

Sample Identifier/Sample Number
Description

Sample Identifier and Sample Number are conditional. The study team must choose one for inclusion on the eCRF form.

Type de données

text

Retour au début de la page

Similar models

Pharmacokinetics GSK study Chronic Coronary Heart Disease NCT00799903

1 Formulaires
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
An unscheduled PK blood sample must be obtained within 72 hours of last dose
pharmacokinetic blood sample
Item
1. Was a pharmacokinetic blood sample obtained?
boolean
Date of blood sample
Item
If yes, date taken
date
Time of blood sample
Item
If yes, time taken
time
date of last investigational product dose prior to PK sample
Item
If Yes, date of last investigational product dose prior to PK sample
date
time of last investigational product dose prior to PK sample
Item
If Yes, time of last investigational product dose prior to PK sample
time
Sample Identifier/Sample Number
Item
Sample Identifier/Sample Number
text
Retour au début de la page 

Aide

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial